StockData
BillionToOne, Inc. logo

BillionToOne, Inc. (BLLN) stock

BLLNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/30
$91.54−5.96 (-6.11%)

Close on Nov 18, 2026Market cap $4.32BP/E –Yield –

BillionToOne operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

BillionToOne's operating income for the twelve months ending Sep 30, 2026 was $44.69M. For fiscal 2025 it was $16.02M.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$16.02M–
FY2024Dec 31, 2024-$47.15M–
FY2023Dec 31, 2023-$69.50M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$11.02M+14.4%
Q2 FY2026Jun 30, 2026$5.50M–
Q1 FY2026Mar 31, 2026$17.83M–
Q4 FY2025Dec 31, 2025$10.33M–
Q3 FY2025Sep 30, 2025$9.63M–
Q2 FY2025Jun 30, 2025-$1.63M–
Q1 FY2025Mar 31, 2025-$2.32M–
Q4 FY2024Dec 31, 2024-$11.69M–
Q3 FY2024Sep 30, 2024-$12.63M–

More BillionToOne figures

See a number that looks wrong?